Key facts
- It has raised $13.3M; the latest was Later Stage VC ($8.2M) in Mar 2026.
- Notable investors include Innovate UK, Scottish Enterprise, Old College Capital, The Scottish National Investment Bank, Archangel Investors — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Bioliberty
- ·The full record, as it builds
Funding rounds
No funding rounds for Bioliberty are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bioliberty
Operator of a biotechnology and medical technology company intended to develop robotic gloves using artificial intelligence for muscle recovery. The company uses assistive robotics and rehabilitative devices that allow users with stroke, motor neuron disease, multiple sclerosis, rheumatoid arthritis, and osteoarthritis to handle hand weakness, enabling patients to handle and improve strength for daily tasks and develop hand strength to live comfortably in their homes.
- Sector
- Healthcare
- HQ
- Edinburgh, United Kingdom
- Founded
- 2020
- Employees
- 28
- Website
- bioliberty.com/
- Ownership
- Privately Held (backing)
Bioliberty doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bioliberty shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bioliberty in its N-PORT filings yet. We sweep new filings monthly.